Commercial Activity

Industrial connections

OPSONA Therapeutics, Collaborator in EU funding scheme. 2005 -

Novo Nordisk, Principal Investigator Tissue Facotr Signalling in chronic inflammatory diseases and atherosclerosis. Jan 2005 - Dec 2007.